These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8595071)

  • 1. Possible modes of action of nimesulide in controlling neutrophilic inflammation.
    Dallegri F; Ottonello L; Bevilacqua M
    Arzneimittelforschung; 1995 Oct; 45(10):1114-7. PubMed ID: 8595071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor].
    Bennett A; Vila D
    Vutr Boles; 2000; 32(1):33-6. PubMed ID: 11195195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation.
    Dallegri F; Patrone F; Ballestrero A; Ottonello L; Ferrando F; Sacchetti C
    Int J Tissue React; 1990; 12(2):107-11. PubMed ID: 2170285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in neutrophilic inflammation?
    Ottonello L; Dapino P; Scirocco MC; Balbi A; Bevilacqua M; Dallegri F
    Clin Sci (Lond); 1995 Mar; 88(3):331-6. PubMed ID: 7736703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological rhythm, inflammation and non-steroidal anti-inflammatory agents].
    Bureau JP; Labrecque G
    Pathol Biol (Paris); 1996 Sep; 44(7):610-7. PubMed ID: 8977918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nonsteroidal antiinflammatory drugs on the neutrophil promoted inactivation of alpha-1-proteinase inhibitor.
    Dallegri F; Ottonello L; Dapino P; Sacchetti C
    J Rheumatol; 1992 Mar; 19(3):419-23. PubMed ID: 1578457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes.
    Ottonello L; Dapino P; Pastorino G; Montagnani G; Gatti F; Guidi G; Dallegri F
    Drugs; 1993; 46 Suppl 1():29-33. PubMed ID: 7506191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nimesulide: 25 years later].
    Mattia C; Ciarcia S; Muhindo A; Coluzzi F
    Minerva Med; 2010 Aug; 101(4):285-93. PubMed ID: 21030939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide.
    Rainsford KD
    Inflammopharmacology; 2006 Aug; 14(3-4):120-37. PubMed ID: 16983492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus.
    Rainsford KD;
    Curr Med Res Opin; 2006 Jun; 22(6):1161-70. PubMed ID: 16846549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral analgesic sites of action of anti-inflammatory drugs.
    Ferreira SH
    Int J Clin Pract Suppl; 2002 Jul; (128):2-10. PubMed ID: 12166614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of a new non-steroid antiinflammatory drug, nimesulide, on activation of the complement system: an in vitro study.
    Auteri A; Saletti M; Blardi P; Di Perri T
    Int J Tissue React; 1988; 10(4):217-21. PubMed ID: 3250936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation?
    Sala A; Folco G
    Biochem Biophys Res Commun; 2001 May; 283(5):1003-6. PubMed ID: 11355871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
    Blackwell TS; Blackwell TR; Holden EP; Christman BW; Christman JW
    J Immunol; 1996 Aug; 157(4):1630-7. PubMed ID: 8759749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered hepatic oxidative phosphorylation and mitochondrial permeability transition in wistar rats treated with nimesulide: Relevance for nimesulide toxicity characterization.
    Moreno AJ; Oliveira PJ; Nova CD; Alvaro AR; Moreira RA; Santos SM; Macedo T
    J Biochem Mol Toxicol; 2007; 21(2):53-61. PubMed ID: 17427176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible anti-inflammatory role of COX-2-derived prostaglandins: implications for inflammation research.
    Kapoor M; Shaw O; Appleton I
    Curr Opin Investig Drugs; 2005 May; 6(5):461-6. PubMed ID: 15912958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents.
    Vajja BN; Juluri S; Kumari M; Kole L; Chakrabarti R; Joshi VD
    Int Immunopharmacol; 2004 Jul; 4(7):901-9. PubMed ID: 15182729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.
    Suda T; Suzuki Y; Matsui T; Inoue T; Niide O; Yoshimaru T; Suzuki H; Ra C; Ochiai T
    Br J Dermatol; 2005 May; 152(5):887-95. PubMed ID: 15888142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of antiinflammatory drugs.
    Vane JR; Botting RM
    Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.